ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.

Authors

Adrienne B Shannon
Richard J Straker
Michael J Carr
James Sun
Karenia Landa
Kirsten Baecher
Kevin Lynch
Harrison G Bartels
Robyn Panchaud, Lehigh Valley Health NetworkFollow
Luke J Keele
Michael C Lowe
Craig L Slingluff
Mark J Jameson
Kenneth Y Tsai
Mark B Faries
Georgia M Beasley
Vernon K Sondak
Giorgos C Karakousis
Jonathan S Zager
John T Miura

Publication/Presentation Date

10-1-2022

Volume

29

Issue

11

First Page

7045

Last Page

7046

ISSN

1534-4681

Published In/Presented At

Shannon, A. B., Straker, R. J., 3rd, Carr, M. J., Sun, J., Landa, K., Baecher, K., Lynch, K., Bartels, H. G., Panchaud, R., Keele, L. J., Lowe, M. C., Slingluff, C. L., Jr, Jameson, M. J., Tsai, K. Y., Faries, M. B., Beasley, G. M., Sondak, V. K., Karakousis, G. C., Zager, J. S., & Miura, J. T. (2022). ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma. Annals of surgical oncology, 29(11), 7045–7046. https://doi.org/10.1245/s10434-022-12293-7

Disciplines

Medical Education | Medicine and Health Sciences

PubMedID

35896923

Department(s)

USF-LVHN SELECT Program, USF-LVHN SELECT Program Students

Document Type

Article